Key result
Metabolic syndrome was associated with a nearly twofold increased risk of newly developed carotid plaque in elderly individuals without prior early carotid atherosclerosis.
Why the study?
Does metabolic syndrome predict the new onset of carotid plaque or progression of C-IMT in an elderly population without early carotid atherosclerosis?
Cohort (n=370)
Single-blind
No
Does metabolic syndrome predict the new onset of carotid plaque or progression of C-IMT in an elderly population without early carotid atherosclerosis?
Metabolic syndrome is an independent predictor of early carotid atherosclerosis progression in the elderly, highlighting its role in initiating the atherosclerotic process.
Answers are grounded in this paper and cite their sources.
May flag elderly without baseline plaque for closer surveillance; leaves open whether metabolic syndrome modification alters progression.
AIMS: To investigate whether metabolic syndrome(MetS) can predict the new onset of carotid plaque or the progression of carotid intima-media thickness(C-IMT) and identify other associated factors in an elderly population without evidence of early carotid atherosclerosis. METHODS: B-mode carotid ultrasonography was used to assess the presence of carotid plaque and the C-IMT at baseline and follow-up. Participants with carotid plaque or an increased C-IMT(≥1.0mm) at baseline were excluded from the study. The new occurrence of carotid plaque, defined as early carotid atherosclerosis and the progression of C-IMT, was evaluated. Multiple regression analyses were used to determine predictors of these findings. RESULTS: A total of 370 participants over 60 years of age(median age=66 years, 34.1% men) were enrolled. After a median follow-up period of 25 months, 64 participants(17.3%) had newly developed carotid plaque. After adjusting for variables determined to be statistically significant in univariate analyses, a multivariable regression analysis showed that predictors of newly developed carotid plaque were metabolic syndrome(hazard ratio [HR]=1.916; 95% confidence interval [CI]: 1.059-3.466), white blood cell count(HR=1.313; 95% CI: 1.094-1.576) and vitamin B12(HR=1.001; 95% CI: 1.000-1.002) and total cholesterol(HR=1.009; 95% CI: 1.001-1.017) levels. A multiple linear regression analysis showed that the rate of change for C-IMT tended to be associated with the development of metabolic syndrome. CONCLUSIONS: Metabolic syndrome is associated with the progression of early carotid atherosclerosis in the general population, suggesting that metabolic syndrome plays an important role in initiating the atherosclerotic process.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2014) conducted a cohort in General elderly population without early carotid atherosclerosis (n=370). Metabolic syndrome vs. Absence of metabolic syndrome was evaluated on New occurrence of carotid plaque (HR 1.916, 95% CI 1.059-3.466, p=0.031). Metabolic syndrome was associated with a nearly twofold increased risk of newly developed carotid plaque in elderly individuals without prior early carotid atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: